3 days ago
VRNA
AnalystsYasmeen RahimiYasmeen Rahimi's Stock Forecasts
AnalystsYasmeen Rahimi
Sectors:
Industries:
Analyst Ranking
Top 5%
#203 out of 4552 analysts
Average Return
+32.92%
Win Rate
42%30 out of 72
Risk vs Reward
Poor
Good
Yasmeen Rahimi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prometheus Biosciences IncRXDX | +681.50% | $24.76 | $193.50 | 2022-06-09 - 2023-04-18 | Strong Buy |
89bio IncETNB | +495.95% | $2.96 | $17.64 | 2022-05-17 - 2023-05-17 | Strong Buy |
Akouos IncAKUS | +346.13% | $2.97 | $13.25 | 2022-05-17 - 2022-10-19 | Strong Buy |
Pliant Therapeutics IncPLRX | +344.83% | $4.84 | $21.53 | 2022-05-17 - 2023-05-17 | Strong Buy |
Madrigal Pharmaceuticals IncMDGL | +311.28% | $46.80 | $192.48 | 2017-10-18 - 2018-10-19 | Strong Buy |
Yasmeen Rahimi Analyst Color
Get additional color on Yasmeen Rahimi's coverage of popular stocks
2 months ago
SVRA
6 months ago
GPCR
6 months ago
IMVT
a year ago
RXDX
a year ago
CBAY
a year ago
ALGS
a year ago
ALGS
2 years ago
RXDX
Yasmeen Rahimi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verona Pharma PLCVRNA | 2 | Strong Buy | $36.00 | +119.51% | Maintains | 3 days ago |
Unicycive Therapeutics IncUNCY | 1 | Strong Buy | $9.00 | +679.22% | Initiates Coverage On | 15 days ago |
Korro Bio IncKRRO | 2 | Strong Buy | $180.00 | +159.74% | Maintains | 23 days ago |
Gossamer Bio IncGOSS | 1 | Strong Buy | $15.00 | +1,729.27% | Maintains | 23 days ago |
Madrigal Pharmaceuticals IncMDGL | 3 | Strong Buy | $336.00 | +47.15% | Reiterates | a month ago |
Edgewise Therapeutics IncEWTX | 1 | Strong Buy | $48.00 | +206.71% | Initiates Coverage On | a month ago |
Savara IncSVRA | 2 | Strong Buy | $16.00 | +222.58% | Maintains | 2 months ago |
Anaptysbio IncANAB | 1 | Strong Buy | $80.00 | +272.61% | Initiates Coverage On | 2 months ago |
Cymabay Therapeutics IncCBAY | 4 | Hold | $32.50 | +0.06% | Downgrades | 2 months ago |
Soleno Therapeutics IncSLNO | 1 | Strong Buy | $93.00 | +145.38% | Initiates Coverage On | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | $37.00 | +84.54% | Initiates Coverage On | 3 months ago |
Structure Therapeutics IncGPCR | 3 | Strong Buy | $93.00 | +150.88% | Maintains | 6 months ago |
Tourmaline Bio IncTRML | 1 | Strong Buy | $65.00 | +289.69% | Initiates Coverage On | 6 months ago |
Immunovant IncIMVT | 2 | Strong Buy | $57.00 | +100.49% | Maintains | 6 months ago |
Sagimet Biosciences IncSGMT | 1 | Strong Buy | $67.00 | +1,546.19% | Initiates Coverage On | 8 months ago |
Protagonist Therapeutics IncPTGX | 3 | Strong Buy | $35.00 | +36.88% | Reiterates | 10 months ago |
Acelyrin IncSLRN | 1 | Strong Buy | $68.00 | +1,254.58% | Initiates Coverage On | a year ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Strong Buy | $56.00 | +27.24% | Initiates Coverage On | a year ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | a year ago |
Allakos IncALLK | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | a year ago |
Chinook Therapeutics IncKDNY | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | a year ago |
Enanta Pharmaceuticals IncENTA | 3 | Strong Buy | $87.00 | N/A | Maintains | a year ago |
Prothena Corp Public Ltd CoPRTA | 1 | Strong Buy | $94.00 | N/A | Initiates Coverage On | a year ago |
Aligos Therapeutics IncALGS | 4 | Strong Buy | $7.00 | N/A | Maintains | a year ago |
Akouos IncAKUS | 2 | Hold | $13.00 | N/A | Downgrades | a year ago |
Cincor Pharma IncCINC | 1 | Strong Buy | $73.00 | N/A | Initiates Coverage On | 2 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $72.00 | N/A | Maintains | 2 years ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $270.00 | N/A | Maintains | 2 years ago |
Reneo Pharmaceuticals IncRPHM | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $27.00 | N/A | Maintains | 2 years ago |
Immunic IncIMUX | 2 | Strong Buy | $39.00 | N/A | Maintains | 2 years ago |
89bio IncETNB | 2 | Strong Buy | $19.00 | N/A | Maintains | 2 years ago |
Altimmune IncALT | 2 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Ventyx Biosciences IncVTYX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Tenaya Therapeutics IncTNYA | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Vaxart IncVXRT | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Liminal Biosciences IncLMNL | 2 | Hold | $45.00 | N/A | Downgrades | 3 years ago |
Design Therapeutics IncDSGN | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 3 years ago |
Albireo Pharma IncALBO | 3 | Strong Buy | $81.00 | N/A | Maintains | 3 years ago |
Amarin Corp PLCAMRN | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 4 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | $77.00 | N/A | Initiates Coverage On | 4 years ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Mirum Pharmaceuticals IncMIRM | 1 | Strong Buy | $77.00 | N/A | Initiates Coverage On | 4 years ago |
Axcella Health IncAXLA | 1 | Strong Buy | $625.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.